
Category Cancer Biomarkers and Therapeutics


Raf kinase inhibitor protein (RKIP) as a novel predictor of molecular targeted therapies response in solid tumors
Read More
SynCroTher – New chromene derivatives for cancer therapy
Read More
Establishment of a patient-derived xenograft CAM model for in vivo validation of the new anticancer drug candidate SM01 – CAMAvatar
Read More
WNTrack – Tracking brain tumors through their exosomes: a WNT6-driven approach
Read More
Exploiting the immune landscape of HOXA9/WNT6-driven glioblastoma: opportunities for novel precision therapies
Read More
Exploiting novel oncogenic players in glioblastoma
Read More
Multi-omic networks in gliomas (MONET)
Read More
Embryonic T-box transcription factor Brachyury: Dissecting its role in prostate cancer biology and clinical application
Read More